JPMorgan Chase & Co. Lowers Recursion Pharmaceuticals (NASDAQ:RXRX) Price Target to $10.00
Recursion Pharmaceuticals (NASDAQ:RXRX – Free Report) had its target price decreased by JPMorgan Chase & Co. from $11.00 to $10.00 in a research note issued to investors on Monday, Benzinga reports. JPMorgan Chase & Co. currently has a neutral rating on the stock. Separately, Needham & Company LLC decreased their target price on Recursion Pharmaceuticals […]
More Stories
Agricultural Bank of China (OTCMKTS:ACGBY) Sets New 1-Year High – Here’s Why
Agricultural Bank of China Limited (OTCMKTS:ACGBY – Get Free Report) shares reached a new 52-week high during mid-day trading on...
Short Interest in Bancolombia S.A. (NYSE:CIB) Rises By 41.9%
Bancolombia S.A. (NYSE:CIB – Get Free Report) was the recipient of a significant growth in short interest in December. As...
Alba Mineral Resources (LON:ALBA) Stock Price Down 4% – Here’s What Happened
Alba Mineral Resources plc (LON:ALBA – Get Free Report)’s stock price traded down 4% during mid-day trading on Monday ....
Esperion Therapeutics (ESPR) – Analysts’ Recent Ratings Changes
Several brokerages have updated their recommendations and price targets on shares of Esperion Therapeutics (NASDAQ: ESPR) in the last few...
Rokmaster Resources (CVE:RKR) Stock Price Up 33.3% – Should You Buy?
Shares of Rokmaster Resources Corp. (CVE:RKR – Get Free Report) traded up 33.3% during trading on Monday . The stock...
Sopra Steria Group SA (OTCMKTS:SPSAF) Short Interest Update
Sopra Steria Group SA (OTCMKTS:SPSAF – Get Free Report) was the target of a large decrease in short interest in...